Furthermore, Mendelian randomisation analysis provided evidence supporting a potential causal link between circulating EDA2R levels and both Alzheimer's disease and all‐cause dementia (Gong et al. 2025). Here, EDA2R is linked to early-onset autosomal dominant Alzheimer disease.